Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-term Safety and Efficacy of Ketohexokinase Inhibition in Patients With Hereditary Fructose Intolerance

NCT06089265 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT06089265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06089265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-term Safety and Efficacy of Ketohexokinase Inhibition in Patients With Hereditary Fructose Intolerance
Lead sponsor
Maastricht University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
June 15, 2023
Completion date
November 30, 2023
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hfi